BlackRock’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.5M | Buy |
|
|||||
|
2025
Q1 | $11.2M | Sell |
|
|||||
|
2024
Q4 | $20M | Sell |
|
|||||
|
2024
Q3 | $20.2M | Buy |
|
|||||
|
2024
Q2 | $17.2M | Sell |
|
|||||
|
2024
Q1 | $20.5M | Buy |
|
|||||
|
2023
Q4 | $23.1M | Sell |
|
|||||
|
2023
Q3 | $42.7M | Buy |
|
|||||
|
2023
Q2 | $33.5M | Buy |
|
|||||
|
2023
Q1 | $2.46M | Sell |
|
|||||
|
2022
Q4 | $7.79M | Sell |
|
|||||
|
2022
Q3 | $5.76M | Sell |
|
|||||
|
2022
Q2 | $3.9M | Hold |
|
|||||
|
2022
Q1 | $8.24M | Hold |
|
|||||
|
2021
Q4 | $7.34M | Sell |
|
|||||
|
2021
Q3 | $7.37M | Hold |
|
|||||
|
2021
Q2 | $7.74M | Sell |
|
|||||
|
2021
Q1 | $7.66M | Hold |
|
|||||
|
2020
Q4 | $8.53M | Buy |
|